IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Clinical trials for IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) explained in plain language.

Never miss a new study

Get alerted when new IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) trials appear

Sign up with your email to follow new studies for IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial aims to help teens with rare bleeding disorder

Disease control Recruiting now

This study is testing a drug called efgartigimod in teenagers (12 to under 18 years old) who have chronic immune thrombocytopenia (ITP), a condition where the immune system attacks blood platelets. The main goal is to find the correct dose and see if it helps increase and maintai…

Matched conditions: IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control

Last updated Mar 27, 2026 12:37 UTC

IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Get alerted when new IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) trials appear

New drug trial aims to help teens with rare bleeding disorder